TITLE

Oral contraceptives did not increase risk for flare in women with systemic lupus erythematosus

PUB. DATE
May 2006
SOURCE
ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p75
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a study about risk factors associated with the use of oral contraceptives (OCs) in women with systemic lupus erythematosus (SLE). This study was conducted on 183 women having 18 to 39 years of age with inactive or stable active SLE. It was found that OC did not differ from placebo for proportions of women having a severe lupus flare or a mild-to-moderate flare. Thus, it was concluded that combined oral contraceptives did not increase risk for severe or mild-to-moderate lupus flare.
ACCESSION #
21490801

 

Related Articles

  • Oral contraceptives did not increase risk for flare in women with systemic lupus erythematosus: COMMENTARY. Denman, Michael // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p75 

    The article presents the author's views regarding a study about risk factors associated with the use of oral contraceptives (OCs) in women with systemic lupus erythematosus (SLE). The study provides evidence that OCs can safely be prescribed for patients with SLE. This form of contraception did...

  • Flares with OCs in nonsevere SLE: what's the risk?  // Reactions Weekly;1/7/2006, Issue 1083, p4 

    This article discusses research being done on the risk of systemic lupus erythematosus flares patients using oral contraceptives. It references a study by Bonnie L. Bermas published in the December 15, 2005 issue of the "New England Journal of Medicine." The effect of oral contraceptives on...

  • Pill linked to increase risk of lupus.  // Podiatry Now;Jun2009, Vol. 12 Issue 6, p14 

    The article presents the results of a study which found that the use of oral contraceptives increased the risk of systemic lupus erythematosus (SLE) in women.

  • Illness intrusiveness explains race-related quality-of-life differences among women with systemic lupus erythematosus. Devins, G. M.; Edworthy, S. M. // Lupus;2000, Vol. 9 Issue 7, p534 

    Our objective was to investigate whether quality of life in systemic lupus erythematosus (SLE) differs across ethnoracial groups and to identify factors that may explain race-related differences. Self-administered questionnaire data from 335 White, 40 Black, and 30 Asian women with SLE were...

  • Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial. G. A. Ferreira; T. P. Navarro; R. W. Telles; L. E. C. Andrade; E. I. Sato // Rheumatology;Sep2007, Vol. 46 Issue 10, p1560 

    Introduction. Patients with systemic lupus erythematosus (SLE) have recognized reduction in endothelium-dependent vasodilation. Evidence demonstrates that statins are able to improve endothelial function independently on their hypolipemic action. Objectives. To evaluate the efficacy of...

  • Hypoparathyroidism in systemic lupus erythematosus. Nashi, E.; Banerjee, D.; Crelinsten, G. // Lupus;2005, Vol. 14 Issue 2, p164 

    We present the case of a man diagnosed with lupus and hypoparathyroidism. This combined diagnosis has very rarely been reported, which is surprising given the evidence that idiopathic hypoparathyroidism can be due to autoimmunity, the multiplicity of organ systems that lupus can affect and the...

  • Application of Reynolds Risk Score for younger generation with different ethnicities. Kawada, T // Lupus;Oct2012, Vol. 21 Issue 11, p1257 

    A letter to the editor is presented in response to the article "Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus" by V. K. Kawai and colleagues in the 2011 issue.

  • Chimerism in systemic lupus erythematosus—three hypotheses. I. C. L. Kremer Hovinga; M. Koopmans; E. de Heer; J. A. Bruijn; I. M. Bajema // Rheumatology;Feb2007, Vol. 46 Issue 2, p200 

    Systemic lupus erythematosus (SLE) is an immune-mediated disease characterized by the presence of autoantibodies and a wide array of clinical symptoms. Despite intensive research, the aetiology of SLE is still unknown and is probably multifactorial. Both genetic and environmental factors have...

  • Late-onset systemic lupus erythematosus: a Latin view. Modesto Santos, Vitorino // Revista de Medicina e Saúde de Brasília;mai-ago2016, Vol. 5 Issue 2, p359 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics